Establishment and characterization of induced pluripotent stem cell line (IGIBi002-A) from a β-thalassemia patient with IVS1-5 mutation by non-integrating reprogramming approach
Summary
β-thalassemia (BT) is a hereditary blood disorder caused by mutations in the β-globin (HBB) gene leading to severely reduced or no synthesis of the β-chain of adult hemoglobin. IVS1-5 (G > C) is the most common BT mutation in Indian population and yet no patient-specific cellular models have been generated. Here, we have established an induced pluripotent stem cell (iPSC) line, IGIBi002-A from a thalassemia patient with a homozygous IVS1-5(G > C) mutation. Characterization of IGIBi002-A demonstrated that these iPSCs are free of exogenous reprogramming genes and expressed pluripotent stem cell markers, exhibited a normal karyotype and were potential of three germ layer differentiation. Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
| Authors | Thakur P, Bhargava N, Jaitly S, Gupta P, Kumar Bhattacharya S, Padma G, Kondaveeti S, Jain S, Ramalingam S |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2020 Dec 10;50:102124 |
| PubMed | 33338925 |
| DOI | 10.1016/j.scr.2020.102124 |